Article Details

Kodiak Sciences completes enrollment in phase 3 GLOW2 trial of tarcocimab tedromer in ...

Retrieved on: 2025-03-11 20:45:43

Tags for this article:

Click the tags to see associated articles and topics

Kodiak Sciences completes enrollment in phase 3 GLOW2 trial of tarcocimab tedromer in .... View article details on hiswai:

Summary

The article details Kodiak Sciences’ trial of tarcocimab tedromer for diabetic retinopathy. Though AMD is noted, the focus is on diabetic retinopathy's complications, aligning with the tags on eye conditions and treatment methods.

Article found on: www.ophthalmologytimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up